Inflammatory bowel disease (IBD) is associated with a number of extraintestinal
complications, including skin lesions. Most reports have shown that skin lesions are found in …

Introduction: Skin manifestations are common in patients with inflammatory bowel diseases
(IBD) and can be part of a concomitant illness with a shared genetic background, an extra …

Inflammatory bowel diseases (IBDs) may be associated with extra-intestinal manifestations.
Among these, mucocutaneous manifestations are relatively frequent, often difficult to …

Inflammatory bowel disease (IBD) with its two main subtypes Crohn's disease and ulcerative
colitis is not restricted to the gastrointestinal tract. Indeed, so-called extraintestinal …

Many extraintestinal cutaneous manifestations can be managed by optimized treatment of
IBD itself, as shared treatment pathways exist. Paradoxical reactions to biologic agents may …

Skin manifestations are common in patients suffering from inflammatory bowel disease (IBD)
and can be associated with the disease itself, with nutritional deficiencies, or with therapy …

The skin is one of the most common extraintestinal organ system affected in patients with
inflammatory bowel disease (IBD), including both Crohn's disease and ulcerative colitis. The …

Objective The use of infliximab in rheumatoid and inflammatory bowel diseases (IBD) has
been associated with a variety of adverse skin reactions, including paradoxical psoriatic …

Background: Ulcerous rectocolitis and Crohn's disease are the best known forms of
inflammatory bowel disease (IBD). Skin manifestations are not uncommon in IBD and may …

BACKGROUND & AIMS:: Psoriasiform and eczematiform lesions are associated with anti–
tumor necrosis factor (TNF)-α therapies. We assessed clinical characteristics, risk factors …